Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127172252 | 12717225 | 2 | F | 201408 | 20160830 | 20160906 | 20160908 | EXP | IT-GLAXOSMITHKLINE-IT2016GSK124581 | GLAXOSMITHKLINE | 53.00 | YR | F | Y | 50.00000 | KG | 20160908 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127172252 | 12717225 | 1 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | U | 0 | TABLET | ||||||||||
| 127172252 | 12717225 | 2 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | 20564 | ||||||||||||
| 127172252 | 12717225 | 3 | C | ABACAVIR. | ABACAVIR | 1 | 0 | ||||||||||||
| 127172252 | 12717225 | 4 | C | NEVIRAPINE. | NEVIRAPINE | 1 | 0 | ||||||||||||
| 127172252 | 12717225 | 5 | C | EFAVIRENZ | EFAVIRENZ | 1 | 0 | ||||||||||||
| 127172252 | 12717225 | 6 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 8 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 9 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 10 | C | OXAZEPAM. | OXAZEPAM | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 11 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 127172252 | 12717225 | 12 | SS | DARUNAVIR | DARUNAVIR | 1 | U | 0 | |||||||||||
| 127172252 | 12717225 | 13 | SS | RITONAVIR. | RITONAVIR | 1 | U | 0 | |||||||||||
| 127172252 | 12717225 | 14 | SS | Dolutegravir | DOLUTEGRAVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127172252 | 12717225 | 1 | HIV infection |
| 127172252 | 12717225 | 2 | HIV infection |
| 127172252 | 12717225 | 12 | HIV infection |
| 127172252 | 12717225 | 13 | HIV infection |
| 127172252 | 12717225 | 14 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127172252 | 12717225 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127172252 | 12717225 | Depression | |
| 127172252 | 12717225 | Diabetes mellitus | |
| 127172252 | 12717225 | Foot fracture | |
| 127172252 | 12717225 | Hypercholesterolaemia | |
| 127172252 | 12717225 | Hypertension | |
| 127172252 | 12717225 | Insomnia | |
| 127172252 | 12717225 | Nightmare | |
| 127172252 | 12717225 | Osteoporosis | |
| 127172252 | 12717225 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127172252 | 12717225 | 6 | 20001122 | 0 | ||
| 127172252 | 12717225 | 7 | 20150114 | 0 | ||
| 127172252 | 12717225 | 8 | 20160204 | 0 | ||
| 127172252 | 12717225 | 9 | 20150114 | 0 | ||
| 127172252 | 12717225 | 10 | 20160204 | 0 |